Regulation of platelet production: The normal response to perturbation and cyclical platelet disease

Journal of Theoretical Biology

Volumn 206, Issue 4, 2000, Pages 585-603

  Santillán, Moisés ^a,b   Mahaffy, Joseph M ^c   Bélair, Jacques ^a,d   Mackey, Michael C ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPOIETIN;

ARTICLE; HUMAN; HUMAN CELL; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; REPRODUCIBILITY; STEADY STATE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 0034699773     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.2000.2149     Document Type: Article

References (73)

1. Garcia's disease: Cyclic thrombocytopenic purpura in a child and abnormal platelet counts in his family
2. Acquired cyclic thrombocytopenia thrombocytosis with periodic defect of platelet function
3. A model for the regulation of mammalian platelet
4. Age-structured and two-delay models for erythropoiesis
5. Purpura thrombopenique et megacaryocytopenie cycliques mensuels
6. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro
7. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+ CD38- bone marrow cells with multilineage potential at the single cell level: Key role of thrombopoietin
8. The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thromobocytopenic purpura (ITP)
9. Cyclic thrombocytopenia associated with multiple antibodies
10. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro
11. Les purpuras thrombopeniques intermittents idiopathiques
12. Structure of the marrow
13. Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission
14. Cyclical thrombocytopenia: Case report and review of literature
15. Cell mediated cyclic thrombocytopenia treated with azathioprine
16. Morbus maculosus werlhofii in regelmassigen vierwochentlichen schuben bei einem 60 jahrigen mann, nebst untersuchungen uber die blutplattchen
17. Thrombopoietin: The primary regulator of megakaryocytopoiesis and thrombopoiesis
18. Modelling thrombopoiesis regulation I: Model description and simulation results
19. The regulation of megakaryocytopoiesis
20. Periodic thrombocytopenia or tidal platelet dysgenesis in a man
21. Periodic chronic myelogenous leukemia: Spectral analysis of blood cell counts and etiological implications
22. Cyclic fluctuations in platelet count, megakaryocyte maturation and thrombopoietin activity in cyanotic congenital heart disease
23. Analysis by analogue and digital computers of the bone marrow stem cell and platelet control mechanisms
24. Modelling thrombopoiesis regulation II: Mathematical investigation of the model
25. Effects of megakaryocyte growth and development factor on platelet production, platelet lifespan, and platelet function in normal human volunteers
26. Cyclical neutropenia and other periodic hematological diseases: A review of mechanisms and mathematical models
27. Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic and cyclical neutropenic patients before and during treatment with G-CSF
28. Haematopoietic dynamics in grey collies
29. Modeling complex neutrophil dynamics in the grey collie
30. Cyclical neutropenia and the peripheral control of white blood cell production
31. Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor
32. Thrombopoietin: The primary regulator of platelet production
33. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development
34. Cyclic change of cytokines in a patient with cyclic thrombocytopenia
35. A mathematical analysis of red blood cell and bone marrow stem cell control mechanisms
36. The physiology of platelet production
37. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan induced thrombocytopenia in the rabbit
38. The purification of thrombocytopenic plasma
39. Evidence for a novel in vivo control mechanism of granulopoiesis: Mature cell-related control of a regulatory growth factor
40. Cyclic thrombocytopenia: A thrombopoietin deficiency
41. A unified hypothesis for the origin of aplastic anemia and periodic haematopoiesis
42. Dynamic haematological disorders of stem cell origin
43. Periodic auto-immune hemolytic anemia: An induced dynamical disease
44. Oscillation and chaos in physiological control systems
45. Hematopoietic model with moving boundary condition and state dependent delay: Applications in erythropoiesis
46. A platelet cycle in normal individuals
47. A study of the interdependence of red cell and bone marrow stem cell populations
48. Biologic effects of thrombopoietin, the Mpl ligand, and its therapeutic potential
49. Megakaryocytes and heterogeneity of circulating platelets
50. Recombinant human thrombopoietin (TPO) stimulates erythropoiesis by inhibiting erythroid progenitor cell apoptosis
51. Thrombopoietin suppresses apoptosis and behaves as a survival factor for the human growth factor-dependent cell line, M07e
52. Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of bax: Potential mechanisms for survival enhancing effects
53. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells
54. A metabolic study of a patient with idiopathic cyclical thrombocytopenic purpura
55. Role of c-Mpl in early hematopoiesis
56. Numerical solution of structured population models: Ii mas structure
57. Cyclical thrombocytopenia: Characterization by spectral analysis and a review
58. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro
59. Adult onset cyclic bicytopenia: A case report and review of treatment of cyclic hematopoiesis
60. Simulation of megakaryocyte and platelet production by a single dose of human recombinant thrombopoietin in patients with cancer
61. Oscillating platelet counts in healthy individuals: Experimental investigation and quantitative evaluation of thrombocytopoietic feedbak control
62. Cyclic thrombocytopenia of acute type
63. A mathematical model of thrombopoiesis in the rat
64. Idiopathic cyclical acute thrombocytopenic purpura
65. Sustaines ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin
66. Periodic production of antiplatelet autoantibody directed against GP IIIa in cyclic thrombocytopenia
67. In vitro senescence and apoptotic cell death of human megakaryocytes
68. In vitro megakaryocytopoietic and thrombopoietic activity of c-Mpl ligand (TPO) on purified murine hematopoietic stem cells